A Strategy Study of Immediate Versus Deferred Initiation of Antiretroviral Therapy for AIDS Disease-Free Survival in HIV-Infected Persons Treated for Tuberculosis With CD4 Less Than 250 Cells/mmexp3.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Efavirenz; Emtricitabine; Emtricitabine/tenofovir disoproxil fumarate; Rifampicin; Tenofovir disoproxil fumarate
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms STRIDE
- 11 Oct 2018 Biomarkers information updated
- 23 Nov 2011 Official Title amended as reported by ClinicalTrials.gov.
- 01 Nov 2011 Trial phase changed from I/II I to IV as reported by ClinicalTrials.gov.